Cellsource
Cellsource runs a regenerative medicine business in Japan, including contract processing of adipose derived stem cells, alongside a consumer business and regenerative medicine centres. It is headquartered in Shibuya, Shibuya-ku, Tokyo, and its shares are listed on the Tokyo Stock Exchange Standard market.
Company Overview
セルソース株式会社
Biotechnology, Life Sciences & Research Tools
Tokyo
166
Japanese-owned
Hiring Activity
- 3
- 0
- 1
Tracked Since: August 2026